Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
30.81
-0.92 (-2.90%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Claritev Revenue
Claritev had revenue of $257.48M in the quarter ending June 30, 2026, with 6.59% growth. This brings the company's revenue in the last twelve months to $994.67M, up 6.32% year-over-year. In the year 2025, Claritev had annual revenue of $965.41M with 3.74% growth.
Revenue (ttm)
$994.67M
Revenue Growth
+6.32%
P/S Ratio
0.52
Revenue / Employee
$331,556
Employees
3,000
Market Cap
522.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 965.41M | 34.79M | 3.74% |
| Dec 31, 2024 | 930.62M | -30.90M | -3.21% |
| Dec 31, 2023 | 961.52M | -118.19M | -10.95% |
| Dec 31, 2022 | 1.08B | -37.89M | -3.39% |
| Dec 31, 2021 | 1.12B | 179.84M | 19.18% |
| Dec 31, 2020 | 937.76M | -45.14M | -4.59% |
| Dec 31, 2019 | 982.90M | -57.98M | -5.57% |
| Dec 31, 2018 | 1.04B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Evolent Health | 2.10B |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| HealthStream | 321.12M |
| Weave Communications | 257.79M |
| So-Young International | 240.51M |
| NRC Health | 140.00M |
CTEV News
- 1 day ago - Claritev Releases 2025 Corporate Responsibility Report - Business Wire
- 3 days ago - Claritev appoints Letham to its Board of Directors - TheFly
- 3 days ago - Claritev Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 3 days ago - Claritev Appoints Ben Letham to its Board of Directors - Business Wire
- 8 days ago - Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Business Wire
- 22 days ago - Claritev Corporation Announces Participation in Upcoming Events - Business Wire
- 4 weeks ago - Claritev price target raised to $40 from $28 at Barclays - TheFly
- 4 weeks ago - Marpai expand relationship with Claritev - TheFly